AI assistant
SI-BONE, Inc. — Director's Dealing 2018
Oct 16, 2018
32647_dirs_2018-10-16_f042f002-75be-4265-a488-fbbc40bffe5a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: SI-BONE, Inc. (SIBN)
CIK: 0001459839
Period of Report: 2018-10-16
Reporting Person: Reckling W Carlton (CMO and VP, Medical Affairs)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (right to buy) | $0.8442 | 2020-09-02 | Common Stock (1111) | Direct | |
| Stock Option (right to buy) | $3.96 | 2023-03-18 | Common Stock (69443) | Direct | |
| Stock Option (right to buy) | $3.24 | 2024-01-16 | Common Stock (8350) | Direct | |
| Stock Option (right to buy) | $3.42 | 2024-07-21 | Common Stock (23865) | Direct | |
| Stock Option (right to buy) | $4.32 | 2026-07-26 | Common Stock (13139) | Direct | |
| Stock Option (right to buy) | $4.32 | 2025-05-25 | Common Stock (11599) | Direct | |
| Stock Option (right to buy) | $4.68 | 2027-03-01 | Common Stock (22363) | Direct |
Footnotes
F1: The shares subject to the option are fully vested and immediately exercisable.
F2: The shares subject to the option vest in equal monthly installments over four years commencing on June 2, 2016, subject to Reporting Person's continued service through each relevant vesting date. The shares subject to this option may be exercised prior to vesting, subject to Issuer's right to repurchase.
F3: The shares subject to the option vest in equal monthly installments over four years commencing on April 15, 2015, subject to Reporting Person's continued service through each relevant vesting date. The shares subject to this option may be exercised prior to vesting, subject to Issuer's right to repurchase.
F4: The shares subject to the option vest in equal monthly installments over four years commencing on September 6, 2017, subject to Reporting Person's continued service through each relevant vesting date. The shares subject to this option may be exercised prior to vesting, subject to Issuer's right to repurchase.